ESCRS - PO0950 - Smile Module For The Treatment Of Hyperopic Residual Refraction Error And Presbyopia After Cataract Surgery

Smile Module For The Treatment Of Hyperopic Residual Refraction Error And Presbyopia After Cataract Surgery

Published 2023 - 41st Congress of the ESCRS

Reference: PO0950 | Type: Free paper | DOI: 10.82333/qeqe-wj96

Authors: Faruk Semiz* 1 , Anita Syla Lokaj 1 , Njomza Hima Musa 1 , Ceren Ece Semiz 1 , Zekeriya Alp Demirsoy 1 , Gokce Idil Semiz 2 , Olcay Semiz 1

1opthtalmology,Eye hospital,pristina,Kosovo, 2Bahcesehir University,Istanbul,Türkiye

Purpose

To investigate the improvement in visual acuity and patient satisfaction after small-incision intrastromal myopic lenticule implantation (SMILE module) in pseudophakic ( trifocal intraocular lens, IOL) patients with hyperopic residual refraction and presbyopia after trifocal  IOL implantation.

Setting

EYE HOSPITAL,KOSOVO

Methods

This included 72 eyes of 36 patients (aged 41 to 61 years).
Postop trifocal IOL implantation included hyperopic residual refraction. They had Phaco surgery in various clinics. Patients had residual hyperopia between +0.75 and +2.75 D and
Astigmatism between +0.50 and +1.50 D.7.70 mm intrastromal pocket was prepared with SMILE Module and Myopic lenticule implanted. 

Results

Patients were followed for one year. No reaction, infection, epithelial defects, punctate keratitis, deep lamellar keratitis, or signs of allogeneic rejection were observed in any of the patients. The UDVA increased from 0.68 ± 0.08 logMAR preoperatively to 0.07 ± 0.02 logMAR 12 months postoperatively (p < 0.001). And UNVA had an increase in J 2 one year after preop J 8.

Conclusions

SMILE module is a reliable method for treating hyperopic residual refraction and presbyopia after trifocal IOL implantation, as it provides results in the shortest time without complications and increases patient satisfaction.

 

NCT04616144

 

NCT04616144

 

NCT04616144